Nucor (NUE) Form 144 — 1,827 Shares to Be Sold via Fidelity on NYSE

Rhea-AI Filing Summary

Nucor Corporation (NUE) filed a Form 144 reporting that a person for whose account the securities are to be sold plans to offer 1,827 common shares for an aggregate market value of $258,173.55. The proposed sale is listed as occurring approximately on 08/12/2025 through Fidelity Brokerage Services LLC on the NYSE.

The securities were acquired as vested restricted stock: 664 shares vested on 06/01/2022 and 1,163 shares vested on 06/01/2023, and payment was recorded as compensation. The filer certifies no undisclosed material adverse information and the form shows Nothing to Report for sales in the past three months.

Insights

Financial Analyst

TL;DR: Small insider sale of 1,827 shares (~$258k) is immaterial relative to the issuer's outstanding shares; appears routine.

The Form 144 discloses a proposed sale of 1,827 common shares with an aggregate market value of $258,173.55. Given the issuer's reported outstanding shares of 230,750,506, the transaction represents a de minimis fraction of float and is unlikely to affect company-level financial metrics. The shares were acquired via restricted stock vesting in 2022 and 2023 and are being sold through a major broker, indicating a standard post-vesting disposition rather than a financing event.

Corporate Governance Expert

TL;DR: Disclosure follows required insider-sale protocols; representation about no material nonpublic information is included.

The filing includes the customary certification that the seller does not possess undisclosed material adverse information and notes the method of acquisition as restricted stock vesting. The planned execution through Fidelity Brokerage Services LLC on the NYSE and the absence of reported sales in the prior three months are consistent with routine insider transactions and rule-compliant disclosure practices. No governance red flags are evident from the form alone.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	1827	258173.55	230750506	08/12/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	06/01/2022	Restricted Stock Vesting	Issuer			664	06/01/2022	Compensation
Common	06/01/2023	Restricted Stock Vesting	Issuer			1163	06/01/2023	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What did Nucor (NUE) report in this Form 144?

The filing reports a proposed sale of 1,827 common shares with an aggregate market value of $258,173.55, to be executed approximately on 08/12/2025 via Fidelity Brokerage Services LLC on the NYSE.

How were the shares being sold acquired?

The shares were acquired as restricted stock vesting: 664 shares on 06/01/2022 and 1,163 shares on 06/01/2023, with payment described as compensation.

Does the Form 144 show any recent sales in the last three months?

No. The filing states "Nothing to Report" for securities sold during the past three months.

Which broker and exchange are listed for the proposed sale?

The broker listed is Fidelity Brokerage Services LLC and the exchange is the NYSE.

Is there any representation about material nonpublic information?

Yes. The signer represents that they do not know any material adverse information about the issuer that has not been publicly disclosed.